Association Between Pococyturia and Pre-eclampsia Severity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

14 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-22

Study Completion Date

2021-03-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Twenty four hours proteinuria is a key element to define pre-eclampsia severity but is delaying the result by 24 hours and constraining for the patient. A simple and rapid indicator for severe preeclampsia would help clinicians to make appropriate decision in patient management. We hypothesized that urinary podocyturia is correlated to preeclampsia severity. This is a prospective, non-interventional, monocentric study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Podocyturia as Predictive Factor for Pre-eclampsia

NCT03316430

Pre-Eclampsia

COMPLETED

Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy

NCT00930397

Pre-eclampsia Intra-uterine Growth Restriction Placental Insufficiency +1 more

COMPLETED

Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

NCT05056701

Preeclampsia

RECRUITING NA

Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients

NCT06059937

Patients Hospitalized for Pre-eclampsia

COMPLETED

A Novel Multiomic AI Approach for Early Preeclampsia Prediction in Pregnancy

NCT06430398

Preeclampsia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pre-Eclampsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-eclampsia

Patients in hospital for pre-eclampsia at the Hopital Femme-Mère-Enfant

Dosage of urinary podocyturia

Intervention Type OTHER

Dosage of urinary podocyturia at admission, delivery and post-partum visit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dosage of urinary podocyturia

Dosage of urinary podocyturia at admission, delivery and post-partum visit

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women aged 18 years or more
* single pregnancy
* admission for pre-eclampsia
* patient receiving information and non-opposition to participate

Exclusion Criteria

* multiple pregnancy
* in utero fetal demise excepted if associated with pre-eclampsia
* antecedent of nephropathy
* fetal malformation, chromosomal anomalies
* inability to understand information provided
* prisoner or under administrative supervision

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No